Načítá se...
Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice
BACKGROUND: Both selenium and non-steroidal anti-inflammatory drug (NSAID) sulindac are effective in cancer prevention, but their effects are affected by several factors including epigenetic alterations and gene expression. The current study was designed to determine the effects of the combination o...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3566909/ https://ncbi.nlm.nih.gov/pubmed/23327547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|